Latest Insider Transactions at Cytokinetics Inc (CYTK)
This section provides a real-time view of insider transactions for Cytokinetics Inc (CYTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CYTOKINETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CYTOKINETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 28
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
Apr 14
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.76%
|
$437,500
$35.61 P/Share
|
|
Apr 14
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
Apr 13
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
4,000
-2.34%
|
$136,000
$34.21 P/Share
|
|
Apr 03
2023
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
530
+2.04%
|
$19,610
$37.71 P/Share
|
|
Apr 03
2023
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+5.09%
|
$11,026
$37.71 P/Share
|
|
Apr 03
2023
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+2.27%
|
$11,026
$37.71 P/Share
|
|
Apr 03
2023
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+2.18%
|
$11,026
$37.71 P/Share
|
|
Apr 03
2023
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
149
+1.26%
|
$5,513
$37.71 P/Share
|
|
Apr 03
2023
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
298
+2.27%
|
$11,026
$37.71 P/Share
|
|
Mar 28
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.76%
|
$437,500
$35.05 P/Share
|
|
Mar 28
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
Mar 15
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-2.76%
|
$462,500
$37.26 P/Share
|
|
Mar 15
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+2.68%
|
$112,500
$9.65 P/Share
|
|
Mar 09
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
4,000
-2.28%
|
$156,000
$39.1 P/Share
|
|
Mar 06
2023
|
Ching Jaw SVP Finance & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+25.57%
|
-
|
|
Mar 06
2023
|
Fady Ibraham Malik EVP Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+18.59%
|
-
|
|
Mar 06
2023
|
Robert Wong VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,000
+17.85%
|
-
|
|
Mar 06
2023
|
Robert I Blum President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
82,500
+15.76%
|
-
|
|
Mar 06
2023
|
Andrew Callos EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,000
+35.85%
|
-
|
|
Mar 06
2023
|
Ching Jaw SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,403
-4.02%
|
$93,717
$39.13 P/Share
|
|
Mar 06
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
4,958
-3.54%
|
$193,362
$39.13 P/Share
|
|
Mar 06
2023
|
Robert Wong VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
692
-3.1%
|
$26,988
$39.13 P/Share
|
|
Mar 06
2023
|
Robert I Blum President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,900
-3.21%
|
$464,100
$39.13 P/Share
|
|
Mar 06
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
12,500
-3.26%
|
$487,500
$39.94 P/Share
|
|
Mar 06
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+3.16%
|
$112,500
$9.65 P/Share
|
|
Mar 02
2023
|
Robert Wong VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,484
-10.02%
|
$96,876
$39.6 P/Share
|
|
Mar 02
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
10,785
-7.15%
|
$420,615
$39.6 P/Share
|
|
Mar 02
2023
|
Ching Jaw SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,225
-9.44%
|
$242,775
$39.6 P/Share
|
|
Mar 02
2023
|
Robert I Blum President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
32,724
-8.12%
|
$1,276,236
$39.6 P/Share
|
|
Mar 02
2023
|
Andrew Callos EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,202
-8.51%
|
$85,878
$39.6 P/Share
|
|
Feb 21
2023
|
Robert Wong VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,234
-8.27%
|
$100,530
$45.21 P/Share
|
|
Feb 16
2023
|
Robert Wong VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
510
-1.85%
|
$22,440
$44.13 P/Share
|
|
Feb 16
2023
|
Ching Jaw SVP Finance & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,210
-1.8%
|
$53,240
$44.13 P/Share
|
|
Feb 16
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
1,513
-0.99%
|
$66,572
$44.13 P/Share
|
|
Feb 16
2023
|
Robert I Blum President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,230
-0.79%
|
$142,120
$44.13 P/Share
|
|
Feb 16
2023
|
Andrew Callos EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
969
-3.61%
|
$42,636
$44.13 P/Share
|
|
Feb 10
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Bona fide gift
|
Direct |
150
-0.1%
|
-
|
|
Feb 09
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
11,000
-3.42%
|
$473,000
$43.74 P/Share
|
|
Feb 09
2023
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+4.1%
|
$49,000
$7.96 P/Share
|
|
Feb 06
2023
|
Wendall Wierenga Director |
SELL
Open market or private sale
|
Direct |
7,000
-35.84%
|
$315,000
$45.0 P/Share
|
|
Feb 06
2023
|
Wendall Wierenga Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+26.38%
|
$42,000
$6.72 P/Share
|
|
Feb 03
2023
|
Ching Jaw SVP Finance & CFO |
SELL
Open market or private sale
|
Direct |
15,000
-18.25%
|
$675,000
$45.0 P/Share
|
|
Feb 03
2023
|
Ching Jaw SVP Finance & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+15.43%
|
$180,000
$12.1 P/Share
|
|
Feb 03
2023
|
Robert Wong VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,004
-9.84%
|
$135,180
$45.0 P/Share
|
|
Jan 17
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$420,000
$42.43 P/Share
|
|
Jan 17
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$90,000
$9.65 P/Share
|
|
Jan 12
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
4,000
-2.49%
|
$160,000
$40.47 P/Share
|
|
Jan 04
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$440,000
$44.24 P/Share
|
|
Jan 04
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$90,000
$9.65 P/Share
|